Annual Surveillance Reports
HIV Surveillance Annual Reports:
HIV Surveillance Mid-Year and Quarterly Reports:
Mid-Year 2019 | Mid-Year 2018 | Mid-Year 2017 | Mid-Year 2016 | Mid-Year 2015 | Mid-Year 2014 | Mid-Year 2013 | Mid-Year 2012 | Mid-Year 2011 | Mid-Year 2010 | Mid-Year 2009 | Mid-Year 2008 | Mid-Year 2007 | Mid-Year 2006 | Mid-Year 2005 | First Quarter 2005 | Fourth Quarter 2004 | Third Quarter 2004 | Second Quarter 2004 | First Quarter 2004
Annual Surveillance Statistics
HIV/AIDS Annual Surveillance Statistics
These tables describe new diagnoses of HIV and AIDS, people with HIV and AIDS, and deaths among people with HIV and AIDS, for New York City overall, and by sex, gender, race/ethnicity, age, borough, transmission category, and neighborhood.
Suggested Citation: HIV Epidemiology Program. HIV/AIDS Annual Surveillance Statistics. New York City Department of Health and Mental Hygiene: New York, NY. November 2023. Accessed [access date] at New York City HIV/AIDS Annual Surveillance Statistics.
Surveillance Slide Sets
Suggested Citation: HIV Epidemiology Program. New York City HIV Surveillance Slide Sets, 2022. New York City Department of Health and Mental Hygiene: New York, NY. November 2023. Accessed [access date] at HIV Epidemiology Program Surveillance Slide Sets.
Age is calculated as age at diagnosis for HIV and AIDS diagnoses; age as of the end of the calendar year for PLWH; and age at death for deaths.
People are classified as having AIDS if they are living with HIV and either have one or more AIDS-defining opportunistic illnesses (based on the 1993 CDC case definition) or a laboratory test indicating suppressed CD4+ cell counts (<200 cells/µL).
Clinical status is determined as of the end of the calendar year or at date of death.
An AIDS diagnosis within 31 days of an HIV diagnosis. People concurrently diagnosed with HIV and AIDS are included in the totals of both HIV diagnoses and AIDS diagnoses.
A diagnosis of HIV is generally based on a positive multi-test algorithm (screening immunoassay, HIV-1/2 differentiation assay, and RNA test) in adults and a positive PCR (polymerase chain reaction) test in infants younger than 18 months. Since June 1, 2000, laboratories and health care providers in New York State have been required to report positive HIV test results even in people without AIDS.
HIV surveillance captures information about risk factors associated with HIV transmission.
The primary risk factors are men who have sex with men (MSM), injection drug use history (IDU), MSM-IDU, heterosexual contact, transgender people with sexual contact (TG-SC), and perinatal transmission.
Men who have sex with men includes men with reported sexual contact with another man, and men with no definitive risk and with history of a rectal STD or proctitis.
The injection drug use category includes people with a history of taking nonprescribed drugs by injection, intravenously, intramuscularly or subcutaneously, excluding men reporting a history of sex with men.
The men reporting a history of sex with men and injection drug use (MSM-IDU) category includes people meeting the definition of both the men who have sex with men and injection drug use categories as described.
The heterosexual contact category includes people who had heterosexual sex with a person they know to be living with HIV, a person who has injected drugs or a person who has received blood products. For women only, also includes history of sex work, multiple sex partners, sexually transmitted disease, crack/cocaine use, sex with a bisexual man, probable heterosexual transmission as noted in medical chart or sex with a man and negative history of injection drug use.
Transgender people with sexual contact includes people identified as transgender at any time by self-report, medical provider or chart review, or ongoing data collection with sexual contact reported and a negative history of injection drug use.
Perinatal transmission is a risk factor for infants who were exposed to HIV during gestation, birth or postpartum through breastfeeding to a mother living with HIV.
Other transmission risk includes people who received treatment for hemophilia, people who received a transfusion or transplant, people with other health care-associated transmission and children with non-perinatal transmission risk.
People with a risk that is unknown have no risk information reported by the provider or an expanded investigation has not been completed for them.
This corresponds to a geographic area within New York City that is an aggregate of between one and nine ZIP codes but is smaller than a borough. UHF neighborhoods reflect catchment areas for certain health care facilities. See the table and map of UHF neighborhoods and corresponding ZIP codes (PDF).
New York State law requires providers to report new diagnoses of HIV, AIDS, and HIV-related illness, and laboratories to report patients’ positive HIV test results, viral loads, CD4 counts, and nucleotide sequences results. The NYC Department of Health and Mental Hygiene investigates provider and laboratory reports to identify transmission risk and dates of diagnosis, and searches for unreported diagnoses.
For more information, call 311 or email HIVreport@health.nyc.gov.
National Behavior Surveillance
Medical Monitoring Project